De Burlo Group’s Hologic HOLX Stock Holding History

De Burlo Group’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5,400	Closed	-$421K	–	83
2024 Q1	$421K	Sell	5,400 -1,400	-21%	-$104K	0.06%	72
2023 Q4	$472K	Hold	6,800	–	–	0.08%	73
2023 Q3	$472K	Hold	6,800	–	–	0.08%	73
2023 Q2	$551K	Buy	6,800 +1,500	+28%	+$123K	0.09%	75
2023 Q1	$428K	Hold	5,300	–	–	0.08%	80
2022 Q4	$396K	Hold	5,300	–	–	0.09%	69
2022 Q3	$342K	Buy	+5,300	New	+$367K	0.08%	73
2022 Q2	–	Sell	-5,400	Closed	-$415K	–	140
2022 Q1	$415K	Hold	5,400	–	–	0.08%	73
2021 Q4	$413K	Buy	5,400 +100	+2%	+$7.35K	0.06%	86
2021 Q3	$391K	Hold	5,300	–	–	0.06%	85
2021 Q2	$354K	Sell	5,300 -62,100	-92%	-$4.15M	0.06%	81
2021 Q1	$5.01M	Sell	67,400 -42,800	-39%	-$3.25M	0.9%	35
2020 Q4	$8.03M	Buy	110,200 +15,700	+17%	+$1.11M	1.31%	30
2020 Q3	$6.28M	Buy	+94,500	New	+$5.98M	1.14%	34
2014 Q1	–	Sell	-9,150	Closed	-$204K	–	99
2013 Q4	$204K	Sell	9,150 -3,000	-25%	-$66.1K	0.05%	101
2013 Q3	$251K	Sell	12,150 -9,650	-44%	-$205K	0.07%	84
2013 Q2	$421K	Buy	+21,800	New	+$455K	0.12%	74

Other funds holding HOLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

De Burlo Group's HOLX Position: Q2 2024 in Review

De Burlo Group sold out of Hologic (HOLX) in Q2 2024, closing a stake of 5,400 shares — an estimated $421K sold.

De Burlo Group first reported a position in HOLX in Q2 2013 and held it in 17 quarters. The position peaked at $8.03M in Q4 2020. 702 funds tracked by Wall St. Rank hold HOLX as of Q2 2024.

De Burlo Group reported no remaining Hologic position as of Q2 2024 after selling out during the quarter.
De Burlo Group sold 5,400 Hologic shares in Q2 2024, an estimated $421K.
De Burlo Group first reported a position in Hologic in Q2 2013 and held it in 17 quarters.
De Burlo Group's Hologic position peaked at $8.03M in Q4 2020.
702 funds tracked by Wall St. Rank held Hologic as of Q2 2024.

Based on De Burlo Group's 13F filing for Q2 2024, filed 14 Aug 2024.